Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Discussion

Session Moderator(s)

• 

  Cathy Eng, MD, FACP, FASCO

  Vanderbilt-Ingram Cancer Center
  MD Anderson Cancer Center

Panelist(s)

• 

  Yelena Y. Janjigian, MD

  Memorial Sloan Kettering Cancer Center
• 

  Anup Kasi, MD, MPH

  Kansas University Cancer Center